• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

    1/20/26 4:30:00 PM ET
    $MTD
    $STE
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Industrial Specialties
    Health Care
    Get the next $MTD alert in real time by email

    Mettler-Toledo International Inc. (NYSE:MTD) announced today that Michael J. Tokich has been appointed to its Board of Directors, effective February 5, 2026.

    Mr. Tokich served for over 17 years as Senior Vice President and Chief Financial Officer ("CFO") at STERIS plc (NYSE:STE), a leading global healthcare and life science provider of products and services, prior to recently transitioning to the role of Senior Financial Advisor at STERIS. Mr. Tokich joined STERIS in 2000 and held various senior financial roles prior to his appointment as CFO in 2008.

    Roland Diggelmann, Chair of the Board, stated, "Mike is a highly accomplished executive who brings nearly two decades of U.S. public company CFO experience to our Board and an impressive track record of sustained growth, operational excellence, and continuous improvement. In addition to his financial expertise, Mike's strong operational and IT experience will bring valuable insights to our business. We look forward to Mike's contributions to our Board."

    METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260120548127/en/

    Adam Uhlman

    Head of Investor Relations

    METTLER TOLEDO

    Direct: 614-438-4794

    adam.uhlman@mt.com

    Get the next $MTD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MTD
    $STE

    CompanyDatePrice TargetRatingAnalyst
    Mettler-Toledo International Inc.
    $MTD
    12/15/2025$1600.00Neutral → Buy
    BofA Securities
    Mettler-Toledo International Inc.
    $MTD
    12/9/2025$1475.00Neutral
    Goldman
    Mettler-Toledo International Inc.
    $MTD
    12/2/2025$1550.00Equal-Weight
    Morgan Stanley
    STERIS plc (Ireland)
    $STE
    7/15/2025$276.00Equal-Weight → Overweight
    Morgan Stanley
    Mettler-Toledo International Inc.
    $MTD
    6/24/2025$1325.00Overweight
    Barclays
    STERIS plc (Ireland)
    $STE
    5/29/2025$263.00Hold
    Jefferies
    Mettler-Toledo International Inc.
    $MTD
    5/20/2025$1350.00Neutral → Buy
    UBS
    Mettler-Toledo International Inc.
    $MTD
    5/5/2025$1110.00Underperform → Hold
    Jefferies
    More analyst ratings

    $MTD
    $STE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Diggelmann Roland D bought $323,360 worth of shares (315 units at $1,026.54), increasing direct ownership by 350% to 405 units (SEC Form 4)

    4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    11/15/23 9:00:20 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    $STE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Tokich Michael J

    3 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    2/6/26 11:23:00 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    New insider Wittorf Oliver claimed ownership of 408 shares (SEC Form 3)

    3 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    1/9/26 11:26:25 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    VP, Chf. Comp. & Quality Offc. Mcgowan Lindsey was granted 798 units of Ordinary Shares, increasing direct ownership by 19% to 5,028 units (SEC Form 4)

    4 - STERIS plc (0001757898) (Issuer)

    1/6/26 4:32:31 PM ET
    $STE
    Industrial Specialties
    Health Care

    $MTD
    $STE
    SEC Filings

    View All

    SEC Form 10-Q filed by STERIS plc (Ireland)

    10-Q - STERIS plc (0001757898) (Filer)

    2/6/26 4:04:07 PM ET
    $STE
    Industrial Specialties
    Health Care

    SEC Form 10-K filed by Mettler-Toledo International Inc.

    10-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

    2/6/26 11:53:50 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

    2/5/26 4:39:49 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    $STE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mettler-Toledo upgraded by BofA Securities with a new price target

    BofA Securities upgraded Mettler-Toledo from Neutral to Buy and set a new price target of $1,600.00

    12/15/25 9:08:50 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Goldman initiated coverage on Mettler-Toledo with a new price target

    Goldman initiated coverage of Mettler-Toledo with a rating of Neutral and set a new price target of $1,475.00

    12/9/25 8:51:34 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Morgan Stanley initiated coverage on Mettler-Toledo with a new price target

    Morgan Stanley initiated coverage of Mettler-Toledo with a rating of Equal-Weight and set a new price target of $1,550.00

    12/2/25 8:27:37 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    $STE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mettler-Toledo International Inc. Reports Fourth Quarter 2025 Results

    Mettler-Toledo International Inc. (NYSE:MTD) today announced fourth quarter results for 2025. Provided below are the highlights: Reported sales increased 8% compared with the prior year. In local currency, sales increased 5% compared with the prior year and included a 1% benefit from acquisitions. Net earnings per diluted share as reported (EPS) were $13.98, compared with $11.96 in the prior-year period. Adjusted EPS was $13.36, an increase of 8% over the prior-year amount of $12.41. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Fourth Quarter Results Patrick Kaltenbach, President and Chief Executive Office

    2/5/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    STERIS Announces Financial Results for Fiscal 2026 Third Quarter

    Total revenue from continuing operations increased 9%; constant currency organic revenue grew 8% As reported EPS from continuing operations increased to $1.96; adjusted EPS increased to $2.53Fiscal 2026 outlook maintained DUBLIN, IRELAND, Feb. 04, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE:STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2026 third quarter ended December 31, 2025. Total revenue from continuing operations for the third quarter of fiscal 2026 increased 9% to $1.5 billion compared with $1.4 billion in the third quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations for the third quarter was 8%. "We are pl

    2/4/26 4:30:00 PM ET
    $STE
    Industrial Specialties
    Health Care

    STERIS Announces Dividend of $0.63 per share

    DUBLIN, IRELAND, Jan. 28, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE:STE) ("STERIS" or the "Company") announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on March 19, 2026, to shareholders of record at the close of business on February 17, 2026.   Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at www.steris-ir.com. STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and serv

    1/28/26 4:30:00 PM ET
    $STE
    Industrial Specialties
    Health Care

    $MTD
    $STE
    Financials

    Live finance-specific insights

    View All

    Mettler-Toledo International Inc. Reports Fourth Quarter 2025 Results

    Mettler-Toledo International Inc. (NYSE:MTD) today announced fourth quarter results for 2025. Provided below are the highlights: Reported sales increased 8% compared with the prior year. In local currency, sales increased 5% compared with the prior year and included a 1% benefit from acquisitions. Net earnings per diluted share as reported (EPS) were $13.98, compared with $11.96 in the prior-year period. Adjusted EPS was $13.36, an increase of 8% over the prior-year amount of $12.41. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Fourth Quarter Results Patrick Kaltenbach, President and Chief Executive Office

    2/5/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    STERIS Announces Financial Results for Fiscal 2026 Third Quarter

    Total revenue from continuing operations increased 9%; constant currency organic revenue grew 8% As reported EPS from continuing operations increased to $1.96; adjusted EPS increased to $2.53Fiscal 2026 outlook maintained DUBLIN, IRELAND, Feb. 04, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE:STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2026 third quarter ended December 31, 2025. Total revenue from continuing operations for the third quarter of fiscal 2026 increased 9% to $1.5 billion compared with $1.4 billion in the third quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations for the third quarter was 8%. "We are pl

    2/4/26 4:30:00 PM ET
    $STE
    Industrial Specialties
    Health Care

    STERIS Announces Dividend of $0.63 per share

    DUBLIN, IRELAND, Jan. 28, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE:STE) ("STERIS" or the "Company") announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on March 19, 2026, to shareholders of record at the close of business on February 17, 2026.   Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at www.steris-ir.com. STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and serv

    1/28/26 4:30:00 PM ET
    $STE
    Industrial Specialties
    Health Care

    $MTD
    $STE
    Leadership Updates

    Live Leadership Updates

    View All

    METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

    Mettler-Toledo International Inc. (NYSE:MTD) announced today that Michael J. Tokich has been appointed to its Board of Directors, effective February 5, 2026. Mr. Tokich served for over 17 years as Senior Vice President and Chief Financial Officer ("CFO") at STERIS plc (NYSE:STE), a leading global healthcare and life science provider of products and services, prior to recently transitioning to the role of Senior Financial Advisor at STERIS. Mr. Tokich joined STERIS in 2000 and held various senior financial roles prior to his appointment as CFO in 2008. Roland Diggelmann, Chair of the Board, stated, "Mike is a highly accomplished executive who brings nearly two decades of U.S. public comp

    1/20/26 4:30:00 PM ET
    $MTD
    $STE
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Industrial Specialties
    Health Care

    CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors

    SAN RAMON, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading medical device company, announced today that the Company's Board of Directors (the "Board") has appointed Walter (Walt) M Rosebrough, Jr. as an independent director, effective as of January 3, 2026. In connection with this appointment, the Company also has entered into a cooperation agreement (the "Cooperation Agreement") with Browning West, LP. ("Browning West"). Mr. Rosebrough will join the Board's Corporate Governance & Nominating Committee. The Board has also agreed that, by the end of 2026, it shall provide due and serious consideration for Mr. Rosebrough to be appointed Chair of the Board. In

    12/23/25 8:00:00 AM ET
    $COO
    $STE
    $VREX
    Ophthalmic Goods
    Health Care
    Industrial Specialties
    Industrial Machinery/Components

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    $MTD
    $STE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by STERIS plc (Ireland) (Amendment)

    SC 13G/A - STERIS plc (0001757898) (Subject)

    2/13/24 5:14:05 PM ET
    $STE
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

    2/13/24 5:09:38 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by STERIS plc (Ireland) (Amendment)

    SC 13G/A - STERIS plc (0001757898) (Subject)

    2/9/24 11:49:03 AM ET
    $STE
    Industrial Specialties
    Health Care